Multiplex Immunoassay for Prediction of Disease Severity Associated with the Cytokine Storm in COVID-19 Cases

Methods Mol Biol. 2022:2511:245-256. doi: 10.1007/978-1-0716-2395-4_18.

Abstract

Severe cases of SARS-CoV-2 and other pathogenic virus infections are often associated with the uncontrolled release of proinflammatory cytokines, known as a "cytokine storm." We present a protocol for multiplex analysis of three cytokines, tumor necrosis factor-alpha (TNF-a), interleukin 6 (IL-6), and IL-10, which are typically elevated in cytokine storm events and may be used as a predictive biomarker profile of disease severity or disease course.

Keywords: COVID-19; Cytokine storm; IL-10; IL-6; Multiplex immunoassay; SARS-CoV-2; TNF-α.

MeSH terms

  • COVID-19* / diagnosis
  • Cytokine Release Syndrome* / diagnosis
  • Cytokines
  • Humans
  • Immunoassay / methods
  • SARS-CoV-2
  • Severity of Illness Index

Substances

  • Cytokines